CN102362950A - Traditional Chinese medicine for treating leucoderma - Google Patents
Traditional Chinese medicine for treating leucoderma Download PDFInfo
- Publication number
- CN102362950A CN102362950A CN2011101698286A CN201110169828A CN102362950A CN 102362950 A CN102362950 A CN 102362950A CN 2011101698286 A CN2011101698286 A CN 2011101698286A CN 201110169828 A CN201110169828 A CN 201110169828A CN 102362950 A CN102362950 A CN 102362950A
- Authority
- CN
- China
- Prior art keywords
- parts
- radix
- fructus
- chinese medicine
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 57
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 238000000034 method Methods 0.000 claims abstract description 12
- 210000000582 semen Anatomy 0.000 claims description 17
- 238000005516 engineering process Methods 0.000 claims description 12
- 229940079593 drug Drugs 0.000 claims description 11
- 241001446509 Psoralea Species 0.000 claims description 8
- 241000545442 Radix Species 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 239000003826 tablet Substances 0.000 claims description 5
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 4
- 239000006187 pill Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- -1 sublimed preparation Substances 0.000 claims description 2
- 241001421953 Eclipta <beetle> Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 29
- 239000008280 blood Substances 0.000 abstract description 25
- 210000004369 blood Anatomy 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 22
- 210000003734 kidney Anatomy 0.000 abstract description 15
- 244000286838 Eclipta prostrata Species 0.000 abstract description 9
- 230000001105 regulatory effect Effects 0.000 abstract description 5
- 230000006870 function Effects 0.000 abstract description 3
- 230000004089 microcirculation Effects 0.000 abstract description 3
- 230000002265 prevention Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 2
- 244000061520 Angelica archangelica Species 0.000 abstract 2
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 2
- 230000003213 activating effect Effects 0.000 abstract 2
- 241001061264 Astragalus Species 0.000 abstract 1
- 244000124209 Crocus sativus Species 0.000 abstract 1
- 235000015655 Crocus sativus Nutrition 0.000 abstract 1
- 241000244987 Daiswa polyphylla Species 0.000 abstract 1
- 241001289529 Fallopia multiflora Species 0.000 abstract 1
- 241000244355 Ligusticum Species 0.000 abstract 1
- 241000830535 Ligustrum lucidum Species 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 241001529733 Nepeta Species 0.000 abstract 1
- 241000304195 Salvia miltiorrhiza Species 0.000 abstract 1
- 235000011135 Salvia miltiorrhiza Nutrition 0.000 abstract 1
- 241001180876 Saposhnikovia Species 0.000 abstract 1
- 241001521901 Tribulus lanuginosus Species 0.000 abstract 1
- 235000006533 astragalus Nutrition 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 210000004233 talus Anatomy 0.000 abstract 1
- 238000010792 warming Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 19
- 201000010099 disease Diseases 0.000 description 17
- 206010025421 Macule Diseases 0.000 description 13
- 208000002193 Pain Diseases 0.000 description 12
- 206010047642 Vitiligo Diseases 0.000 description 12
- 230000007812 deficiency Effects 0.000 description 8
- 210000002216 heart Anatomy 0.000 description 7
- 230000017531 blood circulation Effects 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 239000002994 raw material Substances 0.000 description 6
- 206010040882 skin lesion Diseases 0.000 description 6
- 231100000444 skin lesion Toxicity 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 208000003251 Pruritus Diseases 0.000 description 5
- 239000012567 medical material Substances 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 208000008930 Low Back Pain Diseases 0.000 description 4
- 230000006378 damage Effects 0.000 description 4
- 208000002173 dizziness Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 206010010904 Convulsion Diseases 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 230000036461 convulsion Effects 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 208000001780 epistaxis Diseases 0.000 description 3
- 208000035861 hematochezia Diseases 0.000 description 3
- 230000036737 immune function Effects 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 201000005404 rubella Diseases 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 238000002560 therapeutic procedure Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 208000006820 Arthralgia Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 208000010201 Exanthema Diseases 0.000 description 2
- 208000034507 Haematemesis Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 244000046101 Sophora japonica Species 0.000 description 2
- 235000010586 Sophora japonica Nutrition 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 238000003759 clinical diagnosis Methods 0.000 description 2
- 230000035614 depigmentation Effects 0.000 description 2
- 230000008034 disappearance Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 201000005884 exanthem Diseases 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000004630 mental health Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 231100000957 no side effect Toxicity 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241001521511 Albizia kalkora Species 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 240000002930 Alternanthera sessilis Species 0.000 description 1
- 235000015579 Alternanthera sessilis Nutrition 0.000 description 1
- 241000331777 Arisaema balansae Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007882 Cellulitis Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 208000008967 Enuresis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000034826 Genetic Predisposition to Disease Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010020850 Hyperthyroidism Diseases 0.000 description 1
- 241001313288 Labia Species 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 206010024380 Leukoderma Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010037549 Purpura Diseases 0.000 description 1
- 241001672981 Purpura Species 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- 244000196426 Typhonium divaricatum Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000002605 anti-dotal effect Effects 0.000 description 1
- 230000001363 autoimmune Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019636 bitter flavor Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 244000309146 drought grass Species 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 210000003754 fetus Anatomy 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 210000004905 finger nail Anatomy 0.000 description 1
- 210000003953 foreskin Anatomy 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036074 healthy skin Effects 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000037311 normal skin Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 210000003899 penis Anatomy 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 206010036596 premature ejaculation Diseases 0.000 description 1
- 230000003449 preventive effect Effects 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 231100000241 scar Toxicity 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000004577 thatch Substances 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000820 toxicity test Toxicity 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 210000003905 vulva Anatomy 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to traditional Chinese medicine for treating leucoderma, which is characterized in that eclipta alba, angelica root, angelica, polygonum multiflorum, astragalus campanulatus R.Brown, ligusticum, tribulus terrestris, ligustrum lucidum, nepeta, lithospermum, paris polyphylla, divaricate saposhnikovia root, saffron crocus, purple salvia miltiorrhiza, radix sophorae flavescentis and fructus psoraleae are prepared into various oral preparations according to the conventional pharmacy method. The traditional Chinese medicine has the advantages that the functions of warming and nourishing the liver and the kidney, dispelling the wind, eliminating dampness, regulating qi and blood, clearing and activating the channels and collaterals, activating blood, dissolving stasis and regulating the immunity are realized, the effect of improving the skin micro circulation is reached, the curative effect on the prevention and the treatment of the leucoderma is definite, and the taking is convenient.
Description
Technical field
The present invention relates to skin class treatment of diseases technical field, relate in particular to a kind of technical field of Chinese medicines of treating the vitiligo disease.
Background technology
Vitiligo is a kind of common posteriority, circumscribed depigmentation dermatoses, can betide any age, is more common in child and youth.The sick limitation decolouring speckle that decreases to differing in size, clear-cut margin, on every side with the healthy skin intersection, color of the leather is denseer; Kainogenesis damages common have temporary inflammatory halo, number or single-shot or pilosity on every side, can merge each other in flakes, and the affected part hair can bleach, and does not have any subjective symptoms, and damaging part has bright gargalesthesia after the Exposure to Sunlight.Primary disease is relevant with various autoimmune property disease, like some patients with vitiligo or its relatives, can be associated with hyperthyroidism and go down, diabetes etc.; The organ specific antibody of finding thyroid, stomach, adrenal tissue in some patient's the blood exists.Primary disease often has family history, has family's genetic predisposition.In addition, with body in copper, zinc ion content lower relevant.The patient is many to increase with perspiration, the performance increase in temperature, and diseases such as bleeding time prolongation, the reason that takes place as the vitiligo disease belongs to blood deficiency and blood stasis wind-engaging person more.
At present, it is a lot of to treat this sick method and medicine, but can not reach ideal effect, Therapeutic Method such as " laser ", " skin-grafting ", " freezing " for example, and not only weak curative effect is returned skin and is stayed scar; Some medicine such as patent medicine: the speckle removing ball, remove Bai Su, white macula tincture etc.; These medicines existence take effect slowly, the course of treatment is long; Cure rate low with shortcoming such as relapse rate height; The medicine that has also has irritated and slight toxic reaction, and the medicine that also has is prone to cause side effect such as liver,kidney,spleen enlargement, brings misery to the patient.
Summary of the invention
Technical problem to be solved by this invention provides a kind of to eliminate patient's illness, and the promotion physical and mental health has the leukodermic Chinese medicine of treatment that the patient takes medicine conveniently, curative effect is fast, have no side effect simultaneously.
For solving the problems of the technologies described above; The present invention adopts following technical scheme: the leukodermic Chinese medicine of a kind of treatment, its special character is to be processed by the medicine of following weight proportioning: Herba Ecliptae 30-60 part, Radix Angelicae Dahuricae 30-60 part, Radix Angelicae Sinensis 10-30 part, Radix Polygoni Multiflori 30-60 part, SEMEN ASTRAGALI COMPLANATI 30-60 part, Rhizoma Chuanxiong 15-45 part, Fructus Tribuli 30-60 part, Fructus Ligustri Lucidi 10-30 part, Herba Schizonepetae 10-30 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Rhizoma Paridis 10-30 part, windproof 10-30 part, Stigma Croci 1-2 part, Radix Salviae Miltiorrhizae 10-30 part, Radix Sophorae Flavescentis 10-30 part, Fructus Psoraleae 30-50 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred version is: Herba Ecliptae 40-50 part, Radix Angelicae Dahuricae 40-50 part, Radix Angelicae Sinensis 15-25 part, Radix Polygoni Multiflori 40-50 part, SEMEN ASTRAGALI COMPLANATI 40-50 part, Rhizoma Chuanxiong 25-35 part, Fructus Tribuli 40-50 part, Fructus Ligustri Lucidi 15-25 part, Herba Schizonepetae 15-25 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Rhizoma Paridis 15-25 part, windproof 15-25 part, Stigma Croci 1.2-1.8 part, Radix Salviae Miltiorrhizae 15-25 part, Radix Sophorae Flavescentis 15-25 part, Fructus Psoraleae 35-45 part.
For further solving the problems of the technologies described above; The medicine of the above-mentioned weight proportion of the leukodermic Chinese medicine of treatment of the present invention, its preferred plan is: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
Above-mentioned described Chinese medicine is processed pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
Above-mentioned described Chinese medicine also contains drug excipient.
The principles of formulating prescriptions of Chinese medicine of the present invention are: nourish liver spleen, replenishing QI to invigorate the spleen, nourshing blood and promoting blood circulation, dredge the meridian passage, blood circulation promoting and blood stasis dispelling, set upright and get rid of evils, regulate immunologic function, improve skin microcirculation, reach the leukodermic purpose of treatment.The present invention has proper, the reasonable recipe of compatibility of drugs, and the effect of its said each herbal medicine is:
Herba Ecliptae: another name: Nanjing grass, Alternanthera sessilis (L.) DC., yerbadetajo seed, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae), Herba Ecliptae, Fructus seu radix camptothecae acuminatae (Fructus Camptothecae Acuminatae) are fluffy etc. in vain; Sweet in the mouth, acid, cool in nature; Return liver, kidney channel, have liver and kidney tonifying; The effect of cooling blood for hemostasis; Main deficiency of the liver and kindey, have a dizzy spell, early whitening of beard and hair, haematemesis, spitting of blood, epistaxis, have blood in stool, dysentery, collapse, disease such as leakage, traumatic hemorrhage.
The Radix Angelicae Dahuricae: acrid in the mouth, warm in nature.Go into lung, stomach warp.The effect of the Radix Angelicae Dahuricae, expelling pathogenic wind from the body surface, pain relieving, detumescence and apocenosis, dampness leukorrhagia stopping.
Radix Angelicae Sinensis: hot, the little hardship, warm in nature of sweet in the mouth, return liver spleen heart channel, having enriches blood invigorate blood circulation he, the effect of menstruction regulating and pain relieving, these the article diseases such as row is stagnant, menstruction regulating and pain relieving of can nourishing blood with the Rhizoma Chuanxiong compatibility;
Radix Polygoni Multiflori: sweetness and bitterness, puckery, slightly warm in nature is returned liver, kidney channel, has nourishing the blood and yin, loosening bowel to relieve constipation, preventing the attack (or recurrence) of malaria, dispels the wind, the antidotal effect.Cure mainly a little less than the waist knee joint acid of blood deficiency Light-headedness, cardiopalmus, insomnia, the hepatic and renal YIN deficiency; Early whitening of beard and hair, tinnitus, seminal emission, dryness of the intestine constipation; The chronic malaria body is empty; Diseases such as rubella pruritus, carbuncle sore, scrofula, hemorrhoid.
SEMEN ASTRAGALI COMPLANATI: have another name called: Semen Astragali Complanati.Mature seed for the leguminous plant astragatus complanatus.Be divided into Semen Astragali Complanati, salt SEMEN ASTRAGALI COMPLANATI, fry Semen Astragali Complanati according to different concocting methods, concoct in the back storage drying receptacle, airtight, put the aeration-drying part.Warm in nature, sweet in the mouth, little hardship are returned liver, kidney channel, the matter lubricant nature with; Has the temperature compensation Liver and kidney, controlling nocturnal emission with astringent drugs, reducing urination, the effect that makes eye bright.Be used for lumbago due to renal deficiency, seminal emission premature ejaculation, nebulousurine leukorrhagia, dribbling urination, diseases such as dizzy blurred vision.
Rhizoma Chuanxiong: acrid in the mouth, warm in nature, the effect of promoting flow of QI and blood, wind-expelling pain-stopping is arranged, be used to treat diseases such as menoxenia, amenorrhea dysmenorrhea 、 WEIJIA stomachache, costa sternales twinge, treating swelling and pain by traumatic injury, headache, rheumatic arthralgia;
Fructus Tribuli: another name, thatch, Fructus Tribuli, Fructus Tribuli, Fructus Atriplicis Sibiricae, society Fructus Tribuli soil Fructus Tribuli, Fructus Atriplicis Sibiricae, drought grass, triangle Fructus Tribuli, three JIAOCI, anistree thorn, puncture frame, wild Pedicellus et Pericarpium Trapae, Pedicellus et Pericarpium Trapae thorn etc.; Bitter in the mouth; Hot; Property is put down; Return liver, lung, kidney, heart channel; Effect: suppressing the hyperactive liver, resolving depression, dispelling pathogenic wind for improving eyesight; Cure mainly headache, dizzy, distending pain in the chest and hypochondrium, distending pain of the breast, breast and close diseases such as obstructed, amenorrhea, conjunctival congestion cataracta, rubella pruritus, vitiligo, skin ulcer cellulitis, scrofula.
Fructus Ligustri Lucidi: sweet-bitter flavor, cold nature, return the Liver and kidney warp, have nourishing the liver and kidney, the effect that black hair makes eye bright, these article go into Liver and kidney can benefiting essence-blood, black beard and hair, Pingyin fire, reducing the asthenic fever, is usually used in treating deficiency of the liver and kindey and causes disease;
Herba Schizonepetae: acrid in the mouth, slightly warm in nature, return lung, Liver Channel, have the diffusing wind that induces sweat, rash, the skin ulcer that disappears, hemostatic effect, be usually used in treatment flu, measles pass through send out smooth, have blood in stool, diseases such as metrorrhagia, epistaxis.
Radix Arnebiae (Radix Lithospermi): cold in nature, bitter in the mouth, sweet, flat, be included into the heart, Liver Channel.Effect: removing heat from blood, invigorate blood circulation heat clearing away, detoxifcation.Cure mainly warm macule, jaundice due to damp-heat, purpura tells, nosebleed, hematuria, stranguria with turbid discharge, constipation with heat retention, burn, eczema, erysipelas, diseases such as carbuncle and ulcer.
Rhizoma Paridis: another name: Rhizoma Paridis, Rhizoma Paridis, Typhonium divaricatum (L.) Decne.Character: tubers is cylindrical, and is much more straight, and minority is crooked.Diameter 1～6cm, long 4.5～12cm.The surface yellowish-brown, the minority taupe, more level and smooth; Cold nature, bitter in the mouth; Slightly poisonous.Function cures mainly: heat-clearing and toxic substances removing, reducing swelling and alleviating pain, cool liver arresting convulsion.Make in furuncle swollen carbuncle, laryngopharynx swelling and pain, venom, fall and pounce on the pain of injury, convulsion with spasms.
Windproof: as acrid in the mouth, sweet, slightly warm in nature, to return bladder, liver, spleen channel, have the effect of expelling pathogenic wind from the body surface, removing dampness to relieve pain, relieving convulsion, be used to treat diseases such as diseases caused by exogenous pathogenic factor exterior syndrome, rubella pruritus, rheumatic arthralgia, tetanus.
Stigma Croci: sweet in the mouth, property are put down, and have the effect of blood circulation promoting and blood stasis dispelling, dispersing stagnation and relieving accumulation of pathogens.Be usually used in treating that the chest and diaphragm painful abdominal mass is vexed, haematemesis, typhoid fever are gone mad, frightenedly be afraid of in a trance, women's amenorrhea, diseases such as postnatal blood stasis stomachache, treating swelling and pain by traumatic injury.
Radix Salviae Miltiorrhizae: have another name called Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae, Radix Salviae Miltiorrhizae, Arisaema balansae Engl. etc.Be the dicotyledon Labiatae, dry root and rhizome.Main product in Anhui, ground such as Henan, Shaanxi.The Radix Salviae Miltiorrhizae that records than the Pharmacopoeia of the People's Republic of China because of its root. little, main again production and marketing Yunnan is so claim Radix Salviae Miltiorrhizae, mildly bitter flavor, cold nature again.Red complexion is gone into heart channel; Have reinforcing the heart, hemopoietic nourishes heart, and decides will, calming heart and tranquilizing mind, and forgetful palpitation with a distress feeling, palpitation with fear is insomnia, tissue regeneration promoting blood, blood stasis removing blood, peaceful tire, stillborn fetus falls.Can support the merit that SIWU TANG is enriched blood simply ".
Radix Sophorae Flavescentis: another name: wild Chinese scholartree, brave man's branch, bitter bone, bone, Chinese scholartree, Albizzia kalkora; Cold in nature, bitter in the mouth, GUIXIN, liver, stomach, large intestine, urinary bladder channel; Effect: heat clearing and damp drying, parasite killing, diuresis.Cure mainly: be used for hematodiarrhoea, have blood in stool, jaundice urine retention, leucorrhea with red and white discharge, swelling of the vulva pudendal pruritus, eczema, eczema, skin pruritus, scabies leprosy; External treatment trichomonal vaginitis.
Fructus Psoraleae: acrid in the mouth, warm in nature, nontoxic; Effect with enriching yin and nourishing kidney is usually used in that Yuanyang declines that damage, five kinds of strain and seven kinds of impairment, lumbago due to renal deficiency, kidney qi deficiency and coldness, vital essence are solid, the enuresis, spleen suffer from a deficiency of the kidney and rush down, watery diarrhea chronic dysentery, pregnant woman's lumbago, fall and weigh down diseases such as lumbago, blood stasis stagnate;
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", and all composition comes from the 5th edition medicine that records of China's " pharmacopeia ", and all medicines have the temperature compensation Liver and kidney mutually and altogether, the wind dehumidifying of loosing; The QI and blood regulating, is set upright and is got rid of evils dredge the meridian passage, blood circulation promoting and blood stasis dispelling, regulates immunologic function; Improve skin microcirculation, promote skin pigment to generate the effect of the white and moist skin that disappears; Treatment and prevention vitiligo, determined curative effect have no side effect various Chinese medicine preparation taking conveniences.
Clinical drug of the present invention uses the result to show to have following advantage:
1, the Chinese medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment and the prevention vitiligo of the Chinese medicine of respectively distinguishing the flavor of, and is harmless to human non-toxic.Acute toxicity test and accumulation toxicity test through white mice and rat show that underproof animal does not see any toxic reaction; Compare zero difference through anatomic observation hemogram, liver function, each organs and tissues morphology finding and matched group, prove that its safety of medicine is reliable.
2, Chinese medicine preparation of the present invention need not decoct, not have bitterness sense; Rich in proteins, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid in the medicine; Also contain various trace elements such as Saponin, plant sterol, calcium; Help absorption of human body, health invigorating, and taking convenience.
But 3, Chinese medicine preparation of the present invention efficacious therapy vitiligo not only; And it is also very obvious to leukodermic preventive effect; Particularly pass through working in coordination with each other between the medicine, strengthen medicine and treat characteristic separately, through dredge the meridian passage and adjusting immunologic function; Improve the intrinsic healthy energy of patient body and physical and mental health and life quality, reached the healing rehabilitation efficacy preferably.
Further specify medicine of the present invention to treatment therapy for vitiligo effect through the clinical practice example below.
One, clinical diagnosis standard:
Leukodermic clinical manifestation is: the skin of any department of whole body all can take place, but originates from solar radiation and the damage by friction portion of being prone to, and also can involve like the inboard mucosa of facial area, cervical region, trunk and extremity, lip, labia, glans penis and foreskin.Most of leukasmus is symmetrically distributed, and also has part patient white macula to distribute along nerve segment.Skin lesion is locality depigmentation speckle, milky, big or small from fingernail to coin, circular, oval or irregular shape.White macula place hair also can bleach.In progressive stage, the decolouring speckle is divided a word with a hyphen at the end of a line to normal skin, and development is very fast, and isomorphic response is arranged, and promptly can form the secondary vitiligo after pressure, friction, the wound.
Can divide three types according to the leukoderma scope with distributing:
1, limitation: skin lesion is confined to a position, can be divided into again: (1) segmental pattern: skin lesion is pressed dermatomere and is distributed; (2) mucosal pattern: only involve mucosa.
2, general hair style: the most common, show as skin lesion and be distributed widely in body surface, can be divided into:
(1) homeliness type: skin lesion is dispersed in and is distributed in the body surface many places;
(2) face acra type: skin lesion is distributed in face and far-end of limb;
(3) mixed type: above-mentioned several kinds of various combinations form, like face acra type+segmental pattern etc.
3, whole body type: whole skin all decolours fully or almost, also has hair to bleach.
Two, case selection
Leukodermic sickness rate is with area, the ethnic group colour of skin and different, and the dark more people's sickness rate of general colour is high more.Prevalence is about 0.1-2% in the population of China, and M-F can be fallen ill from the newborn baby about equally until old every year, but is many with teenager.Put down in writing according to interrelated data: age of onset is in the majority in 10-30 year, accounts for 62.65% of sum, and women's age of onset was than male about 5 years ahead of time.For this reason, case selection is whole cases with door rash prescription on individual diagnosis patient.
Three, curative effect determinate standard
Before the curative effect determinate standard that not have at present the promulgation of formal country, the vitiligo curative effect determinate standard that the present invention adopts (the scientific and technological publishing house of Chen Qin chief editor " research and development of Chinese medicine cosmetic health product " Chinese Medicine 1999 version the 228th page) is:
(1) recovery from illness: the white macula complete obiteration, histopathology of skin's inspection is normal;
(2) produce effects: white macula disappears more than 50%, and white macula disappearance portion of tissue pathological examination is normal;
(3) effective: white macula disappearance person accounts for the 20-50% of former white macula area, or in white macula, sees have than the polychrom island;
(4) invalid: no change or white macula enlarge before and after the treatment.
Four, clinical application method and therapeutic outcome
1, clinical application method
According to patient's sick time, the cause of disease and white macula scope and distribution situation, the component medication:
Take the capsule of embodiment 3, each 3-7 gram, every day 2-3 time, warm water delivery service, take half an hour ante cibum.Two months is a course of treatment, take continuously three the course of treatment observe the curative effect.
2, therapeutic outcome
Amount to 89 examples through clinical diagnosis treatment patients with vitiligo, male's 36 examples, women's 53 examples, the age is 12-50 year.Recovery from illness 58 examples account for 65.2% among the 89 routine patients, and produce effects 23 examples account for 25.8%, and effective 6 examples account for 7%, and invalid 2 examples account for 2%, and total effective rate reaches 98%.After treatment, the patient skin white macula disappears in various degree or fully recover, and patient do not have any untoward reaction, three big routine tests and hepatic and renal function detection do not find any unusually.Fully recover through the patient and to pay a return visit statistics, do not see an example recurrence so far.
The specific embodiment
Embodiment 1
Press the row weight portion and take by weighing each Chinese crude drug: 30 parts of Herba Ecliptaes, 30 parts of the Radixs Angelicae Dahuricae, 10 parts of Radix Angelicae Sinensis, 30 parts of Radix Polygoni Multiflori, 30 parts of SEMEN ASTRAGALI COMPLANATIs, 15 parts of Rhizoma Chuanxiong, 30 parts of Fructus Tribulis, 10 parts of Fructus Ligustri Lucidi, 10 parts of Herba Schizonepetae, 15 parts of Radix Arnebiae (Radix Lithospermi)s, 10 parts of Rhizoma Paridis, windproof 10 parts, 1 part of Stigma Croci, 10 parts of Radix Salviae Miltiorrhizae, 10 parts of Radix Sophorae Flavescentiss, 30 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed sublimed preparation according to the pharmaceutical methods that routine prepares sublimed preparation.
Embodiment 2
Press the row weight portion and take by weighing each medical material: 60 parts of Herba Ecliptaes, 60 parts of the Radixs Angelicae Dahuricae, 30 parts of Radix Angelicae Sinensis, 60 parts of Radix Polygoni Multiflori, 60 parts of SEMEN ASTRAGALI COMPLANATIs, 45 parts of Rhizoma Chuanxiong, 60 parts of Fructus Tribulis, 30 parts of Fructus Ligustri Lucidi, 30 parts of Herba Schizonepetae, 45 parts of Radix Arnebiae (Radix Lithospermi)s, 30 parts of Rhizoma Paridis, windproof 30 parts, 2 parts of Stigma Crocis, 30 parts of Radix Salviae Miltiorrhizae, 30 parts of Radix Sophorae Flavescentiss, 50 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed packed powder according to the pharmaceutical methods that routine prepares powder.
Embodiment 3
Press the row weight portion and take by weighing each medical material: 40 parts of Herba Ecliptaes, 40 parts of the Radixs Angelicae Dahuricae, 15 parts of Radix Angelicae Sinensis, 40 parts of Radix Polygoni Multiflori, 40 parts of SEMEN ASTRAGALI COMPLANATIs, 25 parts of Rhizoma Chuanxiong, 40 parts of Fructus Tribulis, 15 parts of Fructus Ligustri Lucidi, 15 parts of Herba Schizonepetae, 25 parts of Radix Arnebiae (Radix Lithospermi)s, 15 parts of Rhizoma Paridis, windproof 15 parts, 1.2 parts of Stigma Crocis, 15 parts of Radix Salviae Miltiorrhizae, 15 parts of Radix Sophorae Flavescentiss, 35 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed capsule according to the pharmaceutical methods that routine prepares capsule.
Embodiment 4
Press the row weight portion and take by weighing each medical material: 50 parts of Herba Ecliptaes, 50 parts of the Radixs Angelicae Dahuricae, 25 parts of Radix Angelicae Sinensis, 50 parts of Radix Polygoni Multiflori, 50 parts of SEMEN ASTRAGALI COMPLANATIs, 35 parts of Rhizoma Chuanxiong, 50 parts of Fructus Tribulis, 25 parts of Fructus Ligustri Lucidi, 25 parts of Herba Schizonepetae, 35 parts of Radix Arnebiae (Radix Lithospermi)s, 25 parts of Rhizoma Paridis, windproof 25 parts, 1.8 parts of Stigma Crocis, 25 parts of Radix Salviae Miltiorrhizae, 25 parts of Radix Sophorae Flavescentiss, 45 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed tablet according to the pharmaceutical methods that routine prepares tablet; (like conventional tablet, sugar coated tablet, film coated tablet etc.), and give conventional drug excipient (like starch, sucrose, lactose, calcium stearate, magnesium stearate etc.).
Embodiment 5
Press the row weight portion and take by weighing each medical material: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed pill according to the pharmaceutical methods that routine prepares pill, and give conventional drug excipient.
Embodiment 6
Press the row weight portion and take by weighing each medical material: 42 parts of Herba Ecliptaes, 42 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 42 parts of Radix Polygoni Multiflori, 42 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 42 parts of Fructus Tribulis, 22 parts of Fructus Ligustri Lucidi, 22 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 22 parts of Rhizoma Paridis, windproof 22 parts, 1.5 parts of Stigma Crocis, 22 parts of Radix Salviae Miltiorrhizae, 22 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
The preparation technology of present embodiment is: above-mentioned each medicinal raw material is processed granule according to the pharmaceutical methods that routine prepares granule.
Claims (5)
1. the leukodermic Chinese medicine of treatment is characterized in that being processed by the medicine of following weight proportioning: Herba Ecliptae 30-60 part, Radix Angelicae Dahuricae 30-60 part, Radix Angelicae Sinensis 10-30 part, Radix Polygoni Multiflori 30-60 part, SEMEN ASTRAGALI COMPLANATI 30-60 part, Rhizoma Chuanxiong 15-45 part, Fructus Tribuli 30-60 part, Fructus Ligustri Lucidi 10-30 part, Herba Schizonepetae 10-30 part, Radix Arnebiae (Radix Lithospermi) 15-45 part, Rhizoma Paridis 10-30 part, windproof 10-30 part, Stigma Croci 1-2 part, Radix Salviae Miltiorrhizae 10-30 part, Radix Sophorae Flavescentis 10-30 part, Fructus Psoraleae 30-50 part.
2. the leukodermic Chinese medicine of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning; Herba Ecliptae 40-50 part, Radix Angelicae Dahuricae 40-50 part, Radix Angelicae Sinensis 15-25 part, Radix Polygoni Multiflori 40-50 part, SEMEN ASTRAGALI COMPLANATI 40-50 part, Rhizoma Chuanxiong 25-35 part, Fructus Tribuli 40-50 part, Fructus Ligustri Lucidi 15-25 part, Herba Schizonepetae 15-25 part, Radix Arnebiae (Radix Lithospermi) 25-35 part, Rhizoma Paridis 15-25 part, windproof 15-25 part, Stigma Croci 1.2-1.8 part, Radix Salviae Miltiorrhizae 15-25 part, Radix Sophorae Flavescentis 15-25 part, Fructus Psoraleae 35-45 part.
3. the leukodermic Chinese medicine of treatment according to claim 1 is characterized in that being processed by the medicine of following weight proportioning: 45 parts of Herba Ecliptaes, 45 parts of the Radixs Angelicae Dahuricae, 20 parts of Radix Angelicae Sinensis, 45 parts of Radix Polygoni Multiflori, 45 parts of SEMEN ASTRAGALI COMPLANATIs, 30 parts of Rhizoma Chuanxiong, 45 parts of Fructus Tribulis, 20 parts of Fructus Ligustri Lucidi, 20 parts of Herba Schizonepetae, 30 parts of Radix Arnebiae (Radix Lithospermi)s, 20 parts of Rhizoma Paridis, windproof 20 parts, 1.5 parts of Stigma Crocis, 20 parts of Radix Salviae Miltiorrhizae, 20 parts of Radix Sophorae Flavescentiss, 40 parts of Fructus Psoraleaes.
4. according to the leukodermic Chinese medicine of the described treatment of arbitrary claim in the claim 1 to 3, it is characterized in that described Chinese patent medicine processes pill, sublimed preparation, powder, tablet, unguentum, decoction and the different oral medicine dosage form of capsule dress powder according to the conventional technology of preparing of Chinese medicine.
5. the leukodermic Chinese medicine of treatment according to claim 4 is characterized in that described Chinese patent medicine also contains drug excipient.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101698286A CN102362950A (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicine for treating leucoderma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2011101698286A CN102362950A (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicine for treating leucoderma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102362950A true CN102362950A (en) | 2012-02-29 |
Family
ID=45689566
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2011101698286A Pending CN102362950A (en) | 2011-06-15 | 2011-06-15 | Traditional Chinese medicine for treating leucoderma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102362950A (en) |
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393903A (en) * | 2013-08-06 | 2013-11-20 | 董云 | Medicament for treating leucoderma |
| CN103705605A (en) * | 2013-12-16 | 2014-04-09 | 崔夕军 | Traditional Chinese medicine for treating leucoderma |
| CN103720821A (en) * | 2014-01-24 | 2014-04-16 | 王兰玲 | External ointment for treating vitiligo antigens and preparation method thereof |
| CN103860930A (en) * | 2014-03-19 | 2014-06-18 | 李常明 | Traditional Chinese medicine composition for effectively treating leucoderma |
| CN105147954A (en) * | 2015-09-29 | 2015-12-16 | 成都倍加特生物科技有限公司 | Medicine powder for treating leucoderma and preparation method thereof |
| CN105194227A (en) * | 2015-10-30 | 2015-12-30 | 吴小斌 | Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills |
| CN105250476A (en) * | 2015-11-13 | 2016-01-20 | 何江思 | Patch used for treating leucoderma and use method thereof |
| CN106038939A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Traditional Chinese medicine for treating leukoderma |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273847A (en) * | 1999-05-14 | 2000-11-22 | 王志明 | Chinese medicine for treating dermatopathy |
-
2011
- 2011-06-15 CN CN2011101698286A patent/CN102362950A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1273847A (en) * | 1999-05-14 | 2000-11-22 | 王志明 | Chinese medicine for treating dermatopathy |
Non-Patent Citations (1)
| Title |
|---|
| 乔桂华等主编: "《中医辨证施治皮肤科疑难病》", 30 November 2006, article "第十二章色素障碍性皮肤病", pages: 310-311 * |
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103393903A (en) * | 2013-08-06 | 2013-11-20 | 董云 | Medicament for treating leucoderma |
| CN103393903B (en) * | 2013-08-06 | 2015-02-25 | 董云 | Medicament for treating leucoderma |
| CN103705605A (en) * | 2013-12-16 | 2014-04-09 | 崔夕军 | Traditional Chinese medicine for treating leucoderma |
| CN103720821A (en) * | 2014-01-24 | 2014-04-16 | 王兰玲 | External ointment for treating vitiligo antigens and preparation method thereof |
| CN103720821B (en) * | 2014-01-24 | 2015-08-19 | 王兰玲 | One treats leukodermic external-applied ointment and preparation method |
| CN103860930A (en) * | 2014-03-19 | 2014-06-18 | 李常明 | Traditional Chinese medicine composition for effectively treating leucoderma |
| CN103860930B (en) * | 2014-03-19 | 2016-06-01 | 刘凤伟 | The Chinese medicine composition of a kind of effective treatment vitiligo |
| CN105147954A (en) * | 2015-09-29 | 2015-12-16 | 成都倍加特生物科技有限公司 | Medicine powder for treating leucoderma and preparation method thereof |
| CN105194227A (en) * | 2015-10-30 | 2015-12-30 | 吴小斌 | Traditional Chinese medicine pills for treating leucoderma and preparation method of traditional Chinese medicine pills |
| CN105250476A (en) * | 2015-11-13 | 2016-01-20 | 何江思 | Patch used for treating leucoderma and use method thereof |
| CN106038939A (en) * | 2016-07-25 | 2016-10-26 | 陈凯 | Traditional Chinese medicine for treating leukoderma |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102416079A (en) | Chinese patent medicine for treating leucoderma | |
| CN103251867A (en) | Chinese herbal compound medicine for treating diabetes mellitus and preparation method thereof | |
| CN102362950A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN103520572A (en) | Traditional Chinese composition used for treating atopic dermatitis as well as preparation method of composition | |
| CN104958607A (en) | Traditional Chinese medicine composition for treating burning mouth syndromes of climacteric women and preparation method thereof | |
| CN101912551B (en) | Miscarriage-prevention Chinese medicinal composition | |
| CN104815192A (en) | A kind of pharmaceutical composition for treating hypertension and its application | |
| CN101897933B (en) | Chinese patent medicament for treating leucoderma | |
| CN103432559A (en) | Traditional Chinese medicine composition for treating spanomenorrhea and dysmenorrhea caused by blood stasis and preparation method and application thereof | |
| CN102178781B (en) | Chinese medicine composition for treating scrotum eczema and preparation method thereof | |
| CN102430013A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN102430097A (en) | Traditional Chinese medicine for treating leucoderma | |
| CN104383257A (en) | Chinese medicinal preparation for treating xerophthalmia due to liver depression and deficiency of yin | |
| CN102727648A (en) | Chinese medicinal composition for treating vitiligo | |
| CN100496585C (en) | Chloasma treating Chinese medicine preparation | |
| CN104784538B (en) | A kind of Chinese medicine preparation and preparation method for the treatment of diabetes | |
| CN103977281A (en) | Traditional Chinese medicine composition for treating female endocrine disorders and preparation method thereof | |
| CN102423433A (en) | Traditional Chinese medicine mixture for treating psoriasis | |
| CN104906430A (en) | Traditional Chinese medicine preparation for treating xerophthalmia and preparation method thereof | |
| CN102406865A (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN103690869B (en) | Chinese medicine for the treatment of irritable bowel syndrome and preparation method thereof | |
| CN102406893A (en) | Chinese patent medicine for treating psoriasis | |
| CN102579895B (en) | Traditional Chinese medicine composition for treating psoriasis | |
| CN105169189A (en) | Medicament for treating hypothyroidism | |
| CN104288581A (en) | Traditional Chinese medicine for treating threatened abortion |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20120229 |